News

The syringes are said to be produced using a hands-free and fully automated process to minimise contamination risks.
Other highlights at Antares Vision Group's Booth N-5844 include a combination plunger rod placement/labelling system for ...
Fort Collins, Colorado, Oct. 19, 2023 (GLOBE NEWSWIRE) -- According to DataHorizzon Research, the Prefilled Syringes Market size was valued at USD 20.4 Billion in 2022 and is expected to have a ...
The intense pressure to develop vaccines and treatments for COVID-19 has helped spur strong growth in the pre-filled syringe market and innovations in syringes and syringe fill/finish operations. “Pre ...
The Food and Drug Administration (FDA) has approved a new 6mg single-dose prefilled syringe for Vabysmo ® (faricimab-svoa). Prior to this approval, Vabysmo had only been available in a single ...
“While other options for CIDP and MG are in development, we believe availability of the prefilled syringe formulation, with self-administration, adds to argenx’s already large competitive moat ...
The FDA approved the Vabysmo 6-mg single-dose prefilled syringe for the treatment of wet age-related macular degeneration, diabetic macular edema and macular edema following retinal vein occlusion ...
The U.S. Food and Drug Administration has approved GSK's prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of shingles (herpes zoster).
As Healio previously reported, the prefilled syringe was approved by the FDA in July. The European Medicines Agency approved the Vabysmo 6 mg prefilled syringe for three retinal conditions.